| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | -17.6% | +8.6% |
| R&D Expense | $22.4M | -19.1% | -26.4% |
| SG&A Expense | $9.2M | -11.6% | -6.5% |
| Operating Income | -$29.4M | +38.2% | +23.1% |
| Income Tax | $0 | — | — |
| Net Income | -$27.5M | +49.1% | +20.6% |
| EPS (Basic) | -$0.30 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.1M | -55.8% | -65.1% |
| Accounts Receivable | $242K | +240.8% | +31.5% |
| Current Assets | $155.5M | -19.2% | -34.5% |
| Total Assets | $195.0M | -11.7% | -43.4% |
| Current Liabilities | $28.1M | -2.9% | -12.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$90.2M | — | — |
| Capital Expenditures | $1.6M | — | — |
| Investing Cash Flow | $84.3M | — | — |
| Financing Cash Flow | $751K | — | — |
| Free Cash Flow | -$91.7M | — | — |
| +21.1% |
| EPS (Diluted) | -$0.30 | +48.3% | +21.1% |
| $53.1M |
| -3.0% |
| -15.8% |
| Stockholders' Equity | $141.8M | -14.6% | -49.6% |